Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer.
Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer. N Engl J Med. 2022 05 26; 386(21):1973-1985.
View in:
PubMed
subject areas
Antineoplastic Agents
Antineoplastic Agents, Immunological
Antineoplastic Combined Chemotherapy Protocols
Carcinoma, Non-Small-Cell Lung
Humans
Ipilimumab
Lung Neoplasms
Neoadjuvant Therapy
Neoplasm Recurrence, Local
Platinum Compounds
authors with profiles
Everett E. Vokes